Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Ciavatta ML, Lefranc F, Carbone M, Mollo E, Gavagnin M, Betancourt T, Dasari R, Kornienko A, Kiss R.

Med Res Rev. 2017 Jul;37(4):702-801. doi: 10.1002/med.21423. Epub 2016 Dec 7. Review.

2.

Δ(9)-THC modulation of fatty acid 2-hydroxylase (FA2H) gene expression: possible involvement of induced levels of PPARα in MDA-MB-231 breast cancer cells.

Takeda S, Ikeda E, Su S, Harada M, Okazaki H, Yoshioka Y, Nishimura H, Ishii H, Kakizoe K, Taniguchi A, Tokuyasu M, Himeno T, Watanabe K, Omiecinski CJ, Aramaki H.

Toxicology. 2014 Dec 4;326:18-24. doi: 10.1016/j.tox.2014.09.011. Epub 2014 Oct 5.

3.

Hypoxia reduces the efficiency of elisidepsin by inhibiting hydroxylation and altering the structure of lipid rafts.

Király A, Váradi T, Hajdu T, Rühl R, Galmarini CM, Szöllősi J, Nagy P.

Mar Drugs. 2013 Dec 2;11(12):4858-75. doi: 10.3390/md11124858.

4.

The yeast sphingolipid signaling landscape.

Montefusco DJ, Matmati N, Hannun YA.

Chem Phys Lipids. 2014 Jan;177:26-40. doi: 10.1016/j.chemphyslip.2013.10.006. Epub 2013 Nov 9. Review.

5.

Predictive factors of sensitivity to elisidepsin, a novel Kahalalide F-derived marine compound.

Serova M, de Gramont A, Bieche I, Riveiro ME, Galmarini CM, Aracil M, Jimeno J, Faivre S, Raymond E.

Mar Drugs. 2013 Mar 20;11(3):944-59. doi: 10.3390/md11030944.

6.

Epithelial-mesenchymal transition markers and HER3 expression are predictors of elisidepsin treatment response in breast and pancreatic cancer cell lines.

Teixidó C, Marés R, Aracil M, Ramón y Cajal S, Hernández-Losa J.

PLoS One. 2013;8(1):e53645. doi: 10.1371/journal.pone.0053645. Epub 2013 Jan 8.

7.

Stereospecificity of fatty acid 2-hydroxylase and differential functions of 2-hydroxy fatty acid enantiomers.

Guo L, Zhang X, Zhou D, Okunade AL, Su X.

J Lipid Res. 2012 Jul;53(7):1327-35. doi: 10.1194/jlr.M025742. Epub 2012 Apr 19.

8.

Irvalec inserts into the plasma membrane causing rapid loss of integrity and necrotic cell death in tumor cells.

Molina-Guijarro JM, Macías Á, García C, Muñoz E, García-Fernández LF, David M, Núñez L, Martínez-Leal JF, Moneo V, Cuevas C, Lillo MP, Villalobos Jorge C, Valenzuela C, Galmarini CM.

PLoS One. 2011 Apr 27;6(4):e19042. doi: 10.1371/journal.pone.0019042.

9.

Chemistry and biology of kahalalides.

Gao J, Hamann MT.

Chem Rev. 2011 May 11;111(5):3208-35. doi: 10.1021/cr100187n. Epub 2011 Apr 11. Review. No abstract available.

10.

Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism.

Van Veldhoven PP.

J Lipid Res. 2010 Oct;51(10):2863-95. doi: 10.1194/jlr.R005959. Epub 2010 Jun 17. Review.

11.

Fatty acid 2-hydroxylase mediates diffusional mobility of Raft-associated lipids, GLUT4 level, and lipogenesis in 3T3-L1 adipocytes.

Guo L, Zhou D, Pryse KM, Okunade AL, Su X.

J Biol Chem. 2010 Aug 13;285(33):25438-47. doi: 10.1074/jbc.M110.119933. Epub 2010 Jun 2.

12.

Fatty acid 2-Hydroxylation in mammalian sphingolipid biology.

Hama H.

Biochim Biophys Acta. 2010 Apr;1801(4):405-14. doi: 10.1016/j.bbalip.2009.12.004. Epub 2009 Dec 21. Review.

13.

Molecular pharmacodynamics of PM02734 (elisidepsin) as single agent and in combination with erlotinib; synergistic activity in human non-small cell lung cancer cell lines and xenograft models.

Ling YH, Aracil M, Jimeno J, Perez-Soler R, Zou Y.

Eur J Cancer. 2009 Jul;45(10):1855-64. doi: 10.1016/j.ejca.2009.03.003. Epub 2009 Apr 5.

Supplemental Content

Support Center